This inventor holds 18 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents, primarily in Antiviral Agents. Top assignees: Bayer Aktiengesellschaft, Aicuris Gmbh + Co. Kg., Bayer Healthcare Aktiengesellschaft. Active years: 1983-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Burscheid, DE (1983 - 1987)
- Wuppertal all of, DE (1991)
- Wuppertal, DE (1989 - 2011)
Company Filing History:
16 out of 12,268 
1 out of 53 
1 out of 77 Years Active: 1983-2011
Areas of Expertise:
Title: Wolfgang Bender: Innovator in Antiviral Applications
Introduction
Wolfgang Bender is a distinguished inventor based in Wuppertal, Germany, known for his remarkable contributions to the field of antiviral agents. With a portfolio of 18 patents, he has significantly advanced therapeutic options for various viral infections. His innovative approach to drug development showcases his dedication to improving human health.
Latest Patents
Among his notable inventions, Bender's latest patents include two groundbreaking advancements. The first is focused on the "Topical application of thiazolyl amides," which pertains to the use of substituted thiazolyl amides in treating herpes infections. This invention not only details effective preparations for topical use but also outlines the production methods involved. The second patent, "Arylsulfonamides as antiviral agents," elaborates on novel sulphonamides designed to combat viral infections, specifically targeting cytomegaloviruses. Both patents reflect Bender's commitment to developing new antiviral treatments that address unmet medical needs.
Career Highlights
Bender has an impressive career history with significant roles at prominent pharmaceutical companies, including Bayer Aktiengesellschaft and Aicuris GmbH & Co. KG. His experience at these organizations has provided him with a solid foundation in pharmaceutical research and development, enabling him to contribute effectively to the field of antiviral drug innovation.
Collaborations
Throughout his career, Wolfgang Bender has collaborated with notable colleagues, including Peter Eckenberg and Andreas Knorr. These partnerships have fostered an environment of shared knowledge and expertise, further enhancing the quality and impact of their research endeavors.
Conclusion
Wolfgang Bender's innovative spirit and dedication to developing antiviral agents have positioned him as a key figure in the pharmaceutical industry. His contributions, marked by 18 patents, reflect a drive to address viral infections effectively. As antiviral research continues to evolve, Bender's work remains a vital part of this important field, promising advancements in treatment options for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile